Mark B. Feinberg

15.9k citations

107 papers · 12.2k indexed · 5 hit papers · h-index 53

Impact in

Virology top 0.02%
- HIV Research and Treatment
Immunology top 0.2%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- T-cell and Retrovirus Studies

Papers in

Virology 74
- HIV Research and Treatment 66
Infectious Diseases 44
- HIV/AIDS Research and Interventions 27
- HIV/AIDS drug development and treatment 20

Co-authors: Flossie Wong‐Staal Silvija I. Staprans Warner C. Greene David Baltimore Richard A. Koup Guido Silvestri Robert C. Gallo Gregory R. Reyes
Journals: Journal of Virology (21 papers)Proceedings of the National Academy of Sciences (10 papers)The Journal of Immunology (6 papers)Nature Medicine (5 papers)Cell (5 papers)
Partner nations: United States France United Kingdom

In The Last Decade

Mark B. Feinberg

106 papers receiving 11.9k citations

Hit Papers

5 papers align trajectories log scale

Changes in thymic function with age and during the treatment of HIV infection 1998 · 1.5k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1998 Nature
1994 The Journal of Experimental Medicine
1988 Cell
1986 Cell
1986 Nature

Peers

Countries citing papers authored by Mark B. Feinberg

Since Specialization

Citations

This map shows the geographic impact of Mark B. Feinberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark B. Feinberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark B. Feinberg more than expected).

Fields of papers citing papers by Mark B. Feinberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark B. Feinberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark B. Feinberg. The network helps show where Mark B. Feinberg may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark B. Feinberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark B. Feinberg Line = papers co-authored together Mark B. Feinberg links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Vaccinology in the artificial intelligence era Science Translational Medicine ·Gianmarco Gasperini, Norman W. Baylor, Steve Black, David E. Bloom, Jakob P. Cramer, Gaël de Lannoy, Philippe Denoël, Mark B. Feinberg, Thibault Helleputte, Gagandeep Kang, William R. Schief, Lynda M. Stuart, Koide Tatsuo, Magdalena Zwierzyna, Rino Rappuoli	2025	1
2	A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates Nature Communications ·Payton A. Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, Shaogeng Tang, Prabhu S. Arunachalam, Mengyun Hu, Ozan S. Kumru, Mary Kate Morris, Jane Fontenot, Lisa Shirreff, Vlasenko Ni, F.E. Ait Mohand, Mr. Lau Shing Lok, Mark B. Feinberg, François Villinger, Carl V. Hanson, Sangeeta B. Joshi, David B. Volkin, Bali Pulendran, Peter S. Kim	2023	54
3	Tetravalent Immunogen Assembled from Conserved Regions of HIV-1 and Delivered as mRNA Demonstrates Potent Preclinical T-Cell Immunogenicity and Breadth Vaccines ·Nathifa Moyo, Edmund G. Wee, Bette Korber, Kapil Bahl, Samantha Falcone, Sunny Himansu, Adrianne L. Wong, Antu Dey, Mark B. Feinberg, Tomáš Hanke	2020	18
4	Role of nonhuman primates in the evaluation of candidate AIDS vaccines: an industry perspective Current Opinion in HIV and AIDS ·Silvija I. Staprans, Mark B. Feinberg, John W. Shiver, Danilo R. Casimiro	2010	14
5	Selective removal of stratum corneum by microdermabrasion to increase skin permeability European Journal of Pharmaceutical Sciences ·Harvinder Singh Gill, Samantha N. Andrews, Senthilkumar K. Sakthivel, Andrew Fedanov, Ifor R. Williams, David A. Garber, Frances Priddy, I. D'emilia, Mark B. Feinberg, Silvija I. Staprans, Mark R. Prausnitz	2009	55
6	Vaccine-Induced, Simian Immunodeficiency Virus-Specific CD8+ T Cells Reduce Virus Replication but Do Not Protect from Simian Immunodeficiency Virus Disease Progression The Journal of Immunology ·Jessica C. Engram, Richard M. Dunham, George Makedonas, Thomas H. Vanderford, Beth Sumpter, Nichole R. Klatt, Sarah J. Ratcliffe, Seema Garg, Mirko Paiardini, Aleksander Нас, John D. Altman, Silvija I. Staprans, Michael R. Betts, David A. Garber, Mark B. Feinberg, Guido Silvestri	2009	27
7	Expanding the Repertoire of Modified Vaccinia Ankara-Based Vaccine Vectors via Genetic Complementation Strategies PLoS ONE ·David A. Garber, Leigh A. O’Mara, Jun Zhao, Sailaja Gangadhara, Janet Williams Hanus, Mark B. Feinberg	2009	31
8	Vaccinia Virus Tropism for Primary Hematolymphoid Cells Is Determined by Restricted Expression of a Unique Virus Receptor Journal of Virology ·Ann Chahroudi, Rahul Chavan, Sun Chuan-bao, Edmund K. Waller, Guido Silvestri, Mark B. Feinberg	2005	63
9	Loss of CD127 Expression Defines an Expansion of Effector CD8+ T Cells in HIV-Infected Individuals The Journal of Immunology ·Mirko Paiardini, Barbara Cervasi, Helmut Albrecht, Alagarraju Muthukumar, Richard M. Dunham, Shari N. Gordon, Henry Radziewicz, Giuseppe Piedimonte, Mauro Magnani, M Montroni, Susan M. Kaech, Amy Weintrob, John D. Altman, Donald L. Sodora, Mark B. Feinberg, Guido Silvestri	2005	191
10	Preclinical Assessment of HIV Vaccines and Microbicides by Repeated Low-Dose Virus Challenges PLoS Medicine ·Roland R. Regoes, Ira M. Longini, Mark B. Feinberg, Silvija I. Staprans	2005	53
11	Disabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinases Nature Medicine ·Patrick M. Reeves, Bettina Bommarius, Sarah L. Lebeis, Donald H French, Jesper Heile Christensen, Alyson Swimm, Ann Chahroudi, Rahul Chavan, Mark B. Feinberg, Darren R. Veach, William G. Bornmann, Melanie A. Sherman, Daniel Kalman	2005	178
12	Blockade of T cell costimulation reveals interrelated actions of CD4+ and CD8+ T cells in control of SIV replication Journal of Clinical Investigation ·David A. Garber, Guido Silvestri, Ashley P. Barry, Andrew Fedanov, Natalia Kozyr, Harold M. McClure, David C. Montefiori, Christian P. Larsen, John D. Altman, Silvija I. Staprans, Mark B. Feinberg	2004	42
13	Blockade of T cell costimulation reveals interrelated actions of CD4+ and CD8+ T cells in control of SIV replication Journal of Clinical Investigation ·David A. Garber, Guido Silvestri, Ashley P. Barry, Andrew Fedanov, Natalia Kozyr, Harold M. McClure, David C. Montefiori, Christian P. Larsen, John D. Altman, Silvija I. Staprans, Mark B. Feinberg	2004	35
14	Quantification of thymic function by measuring T cell receptor excision circles within peripheral blood and lymphoid tissues in monkeys European Journal of Immunology ·Donald L. Sodora, Daniel C. Douek, Guido Silvestri, Lisa Montgomery, Michael Rosenzweig, Tatsuhiko Igarashi, Bruce J. Bernacky, R. Paul Johnson, Mark B. Feinberg, Malcolm A. Martin, Richard A. Koup	2000	71
15	AIDS: Decline and fall of immune surveillance? Current Biology ·Mark B. Feinberg, Angela R. McLean	1997	25
16	Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load The Journal of Immunology ·Thomas Harrer, Ellen G. Harrer, Spyros A. Kalams, Pedro Barbosa, Alicja Trocha, R. Paul Johnson, Tarek Elbeik, Mark B. Feinberg, Susan Buchbinder, Bruce D. Walker	1996	272
17	Activation of virus replication after vaccination of HIV-1-infected individuals. The Journal of Experimental Medicine ·Silvija I. Staprans, Betty L. Hamilton, Stephen Follansbee, Tarek Elbeik, Pedro Barbosa, Robert M. Grant, Mark B. Feinberg	1995	249
18	Intracellular Immunization: Trans -Dominant Mutants of HIV Gene Products as Tools for the Study and Interruption of Viral Replication AIDS Research and Human Retroviruses ·Mark B. Feinberg, Didier Trono	1992	25
19	Molecular insights into human immunodeficiency virus type 1 pathogenesis Current Opinion in Immunology ·Mark B. Feinberg, Warner C. Greene	1992	32
20	Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression. The Journal of Experimental Medicine ·R J Pomerantz, Mark B. Feinberg, Didier Trono, David Baltimore	1990	187

About Mark B. Feinberg

Mark B. Feinberg is a scholar working on Virology, Infectious Diseases, Immunology, Agronomy and Crop Science and Epidemiology, having authored 107 papers that have together received 12.2k indexed citations. Recurring topics across this work include HIV Research and Treatment (66 papers), Immune Cell Function and Interaction (28 papers), HIV/AIDS Research and Interventions (27 papers), HIV/AIDS drug development and treatment (20 papers), T-cell and B-cell Immunology (15 papers), Immunotherapy and Immune Responses (13 papers), Animal Disease Management and Epidemiology (11 papers) and Cytomegalovirus and herpesvirus research (11 papers). The work is most often cited by research in Virology (7.3k citations), Immunology (6.4k citations), Infectious Diseases (3.9k citations), Agronomy and Crop Science (1.1k citations) and Epidemiology (2.9k citations). Mark B. Feinberg has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Flossie Wong‐Staal, Silvija I. Staprans, Warner C. Greene, David Baltimore, Richard A. Koup, Guido Silvestri, Robert C. Gallo, Gregory R. Reyes, Nikki J. Holbrook and Didier Trono. Their work appears in journals such as Journal of Virology, Proceedings of the National Academy of Sciences, The Journal of Immunology, Nature Medicine and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact